ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.2231C>G (p.Ser744Ter) (rs397507282)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000572355 SCV000668649 pathogenic Hereditary cancer-predisposing syndrome 2016-04-28 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge RCV000031358 SCV000326674 pathogenic Breast-ovarian cancer, familial 2 2015-10-02 criteria provided, single submitter clinical testing
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000031358 SCV000300500 pathogenic Breast-ovarian cancer, familial 2 2016-09-08 reviewed by expert panel curation Variant allele predicted to encode a truncated non-functional protein.
GeneDx RCV000481885 SCV000568004 pathogenic not provided 2016-06-02 criteria provided, single submitter clinical testing This pathogenic variant is denoted BRCA2 c.2231C>G at the cDNA level and p.Ser744Ter (S744X) at the protein level. The substitution creates a nonsense variant, which changes a Serine to a premature stop codon (TCA>TGA), and is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant, also denoted BRCA2 2459C>G using alternate nomenclature, has been observed in individuals with a personal and/or family history of breast and/or ovarian cancer (Heidemann 2012, Nielsen 2016) and is considered pathogenic.
Sharing Clinical Reports Project (SCRP) RCV000031358 SCV000053963 pathogenic Breast-ovarian cancer, familial 2 2008-03-25 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.